NF-KappaB interacting LncRNA: Review of its roles in neoplastic and non-neoplastic conditions

NF-KB Interacting LncRNA (NKILA) is a long non-coding RNA (lncRNA) which has inhibitory roles on NF-KB. NFKB regulates expression of several molecules participating in various crucial physiological reaction including immune responses, cell proliferation and differentiation, as well as cell death. Therefore, NKILA can be involved in the pathogenesis of a wide spectrum of human disorders. Numerous studies in hepatocellular carcinoma, breast cancer, melanoma, glioma and other types of neoplasms have indicated the role of NKILA in blockage of tumor growth and inhibition of metastasis. Further in vitro and in vivo assays including apoptosis assays, knockdown and knock-in experiments have verified such roles. In addition to its roles in neoplastic conditions, NKILA is involved in the pathogenesis of immune-related disorders. Dysregulation of expression of NKILA has been reported in patients with diverse conditions such as epilepsy, osteoarthritis, periodontitis and coronary artery disease. In this paper, we recapitulate the contribution of NKILA in neoplastic and non-neoplastic conditions.

Automated summary

NF-KB interacting lncRNA (NKILA) is a long non-coding RNA that inhibits NF-KB and plays a role in the pathogenesis of both neoplastic and non-neoplastic conditions. Its dysregulation has been reported in various diseases such as epilepsy and osteoarthritis.